Andrew Berens

Andrew Berens

Analyst-Equity at Leerink Partners LLC

Finance
Consumer Services

Profile

Dr. Andrew Berens is a Senior Managing Director at Leerink Partners LLC.
He is a Senior Research Analyst at Leerink Partners covering Targeted Oncology.
Prior to joining the firm in June 2018, Dr. Berens was an Executive Director and Senior Biotechnology Research Analyst at Morgan Stanley focusing on mid and small cap biotechnology companies.
Dr. Berens practiced as an Emergency Medicine Physician for a decade before starting his career in equity research.
He also worked in the pharma industry at Ikaria Pharmaceuticals, where he was a Senior Director in business development, leading search and development efforts.
Dr. Berens earned MBA degrees from Columbia Business School and London Business School, his M.D.
from Emory University and an undergraduate degree in English Literature from Tulane University.

Andrew Berens active positions

CompaniesPositionStart
Analyst-Equity 2018-05-31
All active positions of Andrew Berens

Former positions of Andrew Berens

CompaniesPositionEnd
Analyst-Equity 2018-05-31
Analyst-Equity 2015-02-27
Corporate Officer/Principal 2014-04-29
Analyst-Equity 2009-03-30
Analyst-Equity 2007-03-29
See the detail of Andrew Berens's experience

Training of Andrew Berens

Columbia Business School Masters Business Admin
Emory University School of Medicine Doctorate Degree
Tulane University (Louisiana) Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Berens's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies6

Finance

Finance

Finance

Finance

Finance

Finance

See company connections